Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

AdaptHealth (AHCO) EPS (Weighted Average and Diluted) (2019 - 2026)

AdaptHealth has reported EPS (Weighted Average and Diluted) over the past 7 years, most recently at -$0.73 for Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) fell 314.71% year-over-year to -$0.73; the TTM value through Dec 2025 reached -$0.52, down 186.67%, while the annual FY2025 figure was -$0.52, 185.25% down from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was -$0.73 at AdaptHealth, down from $0.16 in the prior quarter.
  • Over five years, EPS (Weighted Average and Diluted) peaked at $0.4 in Q4 2021 and troughed at -$3.43 in Q3 2023.
  • A 5-year average of -$0.22 and a median of $0.09 in 2022 define the central range for EPS (Weighted Average and Diluted).
  • Biggest five-year swings in EPS (Weighted Average and Diluted): surged 200.0% in 2022 and later plummeted 9600.0% in 2023.
  • Year by year, EPS (Weighted Average and Diluted) stood at $0.4 in 2021, then tumbled by 105.0% to -$0.02 in 2022, then plummeted by 9600.0% to -$1.94 in 2023, then skyrocketed by 117.53% to $0.34 in 2024, then plummeted by 314.71% to -$0.73 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for AHCO at -$0.73 in Q4 2025, $0.16 in Q3 2025, and $0.1 in Q2 2025.